Paxneury 4 mg prolonged-release tablets

Licence status
Authorised: 26/02/2025
Active substances
Guanfacine hydrochloride
Dosage Form
Prolonged-release tablet
Licence number
EU/1/24/1908/004
Licence holder
Neuraxpharm Pharmaceuticals S.L.

Product documents

Licence information

ATC code
C02AC02 guanfacine
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
26/02/2025